Buradasınız

Anasayfa » Content

Birinci basamakta demir ve B12 eksikliği anemilerine yaklaşım

Approach to iron and B12 deficiency anemia in primary care

Journal Name:

  • Smyrna Tıp Dergisi

Publication Year:

  • 2012

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Anemia is a disorder characterized by decreased red cell mass. Iron deficiency anemia is the most common cause of anemia worldwide. Pernicious anemia is a macrocytic anemia, develops due to a lack of intrinsic factor which provides the absorption of linking dietary vitamin B12 from the terminal ileum. Anemia is common in primary care and is a clinical need obtaining information about diagnosis, treatment and follow-up by physicians. Our goal is to evaluate approaches to two common types of anemia in our country, that are iron and vitamin B12 deficiency anemias.
Bookmark/Search this post with
Abstract (Original Language): 
Anemi eritrosit kitlesinde azalma ile kendini gösteren bir bozukluktur. Demir eksikliği anemisi dünya çapında en sık anemi nedenidir. Pernisiyöz anemi diyet ile alınan B12 vitaminini bağlayarak terminal ileumdan absorbe edilmesini sağlayan intrensek faktör eksikliğine bağlı olarak gelişen bir makrositik anemidir. Anemi, birinci basamakta sık karşılaşılan, hekimler tarafından tanı, tedavi ve izlemi hakkında bilgi edinilmesi gereken klinik bir durumdur. Amacımız ülkemizde sık görülen iki anemi çeşidi olan; demir ve vitamin B12 eksikliği anemilerine yaklaşımı değerlendirmektir.
FULL TEXT (PDF): 
PDF icon arastirmax-birinci-basamakta-demir-b12-eksikligi-anemilerine-yaklasim.pdf
  • 1
51-53
  • Turkish

REFERENCES

References: 

1. Semenza GL. O2-regulated gene expression:
Transcriptional control of cardiorespiratory physiology
by HIF-1. J Appl Physiol 2004; 96(3):1173-1177.
2. Vatner SF. Effects of hemorrhage on regional blood flow
distribution in dogs and primates. J Clin Invest 1974;
54(2):225-235.
3. Erslev AJ. Erythropoietin. N Engl J Med 1991;
324(19):1339-1344.
4. WHO worldwide prevalance of anaemia 1993-2005:
WHO global database on anaemia. Geneva: World
Health Organization; 2008.
5. Andrews NC. Disorders of iron metabolism. N Engl J
Med 1999; 341(26):1986-1995.
6. Capurso G, Baccini F, Osborn J, Panzuto F, Di Giulio E,
Delle Fave G. Can patient characteristics predict the
outcome of endoscopic evaluation of iron deficiency
anemia: a multiple logistic regression analysis.
Gasrointest Endosc 2004; 59(7):766-771.
7. Annibale B, Capurso G, Chistolini A, D'Ambra G,
DiGiulio E, Monarca B. Gastrointestinal causes of
refractory iron deficiency anemia in patients without
gastrointestinal symptoms. Am J Med 2001; 111(6):439-
445.
8. Allen LH. Iron supplements: scientific issues concerning
efficacy and implications for research and programs. J
Nutr 2002; 132(4 Suppl):813S-95.
9. D'Elios MM, Appelmelk BJ, Amedei A, Bergman MP,
Del Prete G. Gastric autoimmunity: the role of
Helicobacter pylori and molecular mimicry. Trends Mol
Med 2004; 10(7):316-323.
10. Hvas AM, Nexo E. Diagnosis and treatment of vitamin
B12 deficiency-an update. Haematologica 2006;
91(11):1506-1512.
İletişim:
Yrd.Doç.Dr. Serkan Ocakçı
İzmir Üniversitesi Medicalpark Hastanesi
İç Hastalıkları ve Hematoloji Kliniği, İzmir, Türkiye
Tel: +90.532.2574212
e-mail:serkan.ocakci@medicalpark.com.tr

Thank you for copying data from http://www.arastirmax.com